Carbidopa/levodopa extended-release capsules price range and purchase channels

Carbidopa/levodopa sustained-release capsules (carbidopa and levodopa), trade nameCREXONT, are a compound drug used to treat Parkinson's disease and Parkinson's syndrome. Sometimes called paralysis shaking or paralysis shaking.

Parkinson's disease is a disease of the central nervous system (brain and spinal cord). The combination of carbidopa and levodopa is also used to treat parkinsonism caused by encephalitis, or parkinsonism caused by carbon monoxide or manganese poisoning. Dopamine is a naturally occurring substance in the brain that helps control movement and activities, such as walking and talking. In people with Parkinson's disease, certain parts of the brain don't have enough dopamine. Levodopa enters the brain and helps replace missing dopamine, allowing people to function better. By increasing the amount of dopamine in your brain, levodopa helps control symptoms and helps you with daily activities, such as dressing, walking, and handling dishes.

The drug was approved for marketing by the U.S. Food and Drug Administration (FDA) on August 7, 2024, providing patients with a new treatment option. However, due to its short time on the market, its price information is not yet clear. Patients can learn about market pricing trends by paying attention to the drug price updates released by the FDA or professional pharmaceutical media or industry reports.

For patients who are in urgent need of medication, they can obtain drugs through regular overseas medical consultation institutions. These institutions usually cooperate with foreign pharmacies or pharmaceutical companies to provide drug purchasing and distribution services.

It should be noted that when purchasing, you need to ensure that the source of medicines is regular and avoid buying fake and shoddy products. Medications need to be stored at room temperature between 20°C and 25°C and high temperature and humidity need to be avoided during transportation. During medication, you need to pay close attention to adverse reactions. If serious symptoms occur, you should seek medical treatment in time.

Carbidopa/ Levodopa sustained-release capsules provide a new treatment option for patients with Parkinson's disease, but due to its short time on the market, its price information is not yet clear. Patients can obtain the latest updates and purchasing channels through the FDA's official website, pharmaceutical news or regular overseas medical consulting agencies. During the purchase and use process, it is necessary to ensure that the medicine comes from a regular source and strictly follow the doctor's instructions to ensure that the medicine is safe and effective. As the market matures, the drug's price and purchase channels will become more transparent and convenient, bringing good news to more patients.

Reference link: https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/217186s000lbl.pdf